Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announced on October 7, 2026 that it has entered into agreements with Wittington Investments, Limited — the Weston family's Canadian holding company — to acquire The Boots Group, the leading pharmacy and health and beauty retailer in the United Kingdom and Ireland, for a total purchase price of approximately US$8.9 billion inclusive of assumed debt. Fairfax has committed up to approximately US$2.3 billion in equity and is expected to hold a 50% ownership stake following closing. The transaction is expected to close in the first quarter of 2027, subject to customary conditions.

Key Points

  • Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announced the Boots Group acquisition agreement on October 7, 2026.
  • Fairfax and Wittington Investments have agreed to acquire The Boots Group for approximately US$8.9 billion, inclusive of assumed debt.
  • Fairfax has committed up to approximately US$2.3 billion in equity; it is expected to own 50% of Boots post-closing, with Wittington retaining operational control.
  • Investors will be watching whether all customary closing conditions are satisfied ahead of the anticipated Q1 2027 completion date.

Fairfax's US$2.3 Billion Equity Commitment and Ownership Structure

Under the terms disclosed, Fairfax has entered into an equity commitment letter agreeing to contribute up to approximately US$2.3 billion toward the purchase price. Following closing, Fairfax is expected to own 50% of the equity of Boots. Wittington will retain operational control of the business, with Galen Weston serving as Chair of Boots. The announcement notes that the transaction does not include Boots' businesses in Germany and Mexico, which will be retained by their current owner, limiting the scope of the acquisition to the UK and Ireland operations.

Wittington's Retail Track Record Behind the Partnership Rationale

Wittington Investments is the private holding company for the Weston family and the controlling shareholder of George Weston Limited, which in turn controls Loblaw Companies Limited and Choice Properties. Loblaw operates more than 2,800 locations across Canada and owns Shoppers Drug Mart, the country's largest pharmacy, health and beauty business. The release suggests this established pharmacy and retail expertise is central to the partnership's strategic rationale, with Fairfax citing the Westons' record of growing successful Canadian retail brands as a key factor in the arrangement.

Boots' Market Position in the UK and Ireland

The Boots Group is described in the announcement as the leading pharmacy and health and beauty retailer in the United Kingdom and Ireland. Chairman and CEO Prem Watsa characterised Boots as a "leading historic brand," while Galen Weston described it as "one of Britain's most enduring businesses." The release states that long-term ownership, capital investment, and renewed operating focus are among the priorities the new partners intend to bring to the business. The transaction remains subject to customary closing conditions ahead of the expected Q1 2027 completion.